September 14, 2015
Takeda takes part in WIPO Re:Search
Takeda Pharmaceutical Company Limited will participate in WIPO Re:Search, a consortium to accelerate research and development (R&D) of new drugs, vaccines,…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
September 13, 2015
European Commission approves Tafinlar and Mekinist combination
The European Commission has approved the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with…
September 13, 2015
Strensiq in HPP patiens therapy get approval from European Commission
Alexion Pharmaceuticals, Inc. announced on September 1, 2015, that the European Commission has approved Strensiq (asfotase alfa) for long-term enzyme replacement…
June 15, 2015
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray
The National Institute on Drug Abuse (NIDA) has announced that Adapt Pharma Limited, a partner of Lightlake Therapeutics Inc., has started a rolling…
June 15, 2015
Cosentyx meets the primary endpoints
Cosentyx (secukinumab) met the primary endpoints of superiority compared to placebo in patients with difficult-to-treat psoriasis of the nails, palms…
June 15, 2015
Novartis: Long -term disease control for polycythemia vera patients treated with Jakavi
Novartis announced data that show majority of patients with polycythemia vera treated with Jakavi achieved long-term disease control. The company said…
June 7, 2015
Xolair treats CSU patients better than placebo
Novartis reports new analysis showing Xolair® improving quality of life by 78% for chronic spontaneous urticaria patients New analysis from…